We validated this finding in a second independent scRNA-seq dataset from full-thickness skin biopsies of lesional skin of three additional DM patients (Methods, Fig. 2H23), and IFNB1 was again predominantly expressed by CD14+ cells (Fig. S2E,F). The gene discussed is IFNB1; the disease is dermatomyositis.